Singing with Page and Metallica, flirting with Hendrix, getting high with Clapton – the late Marianne Faithfull did it all ...

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- According to former CIA insider Jim Rickards, artificial intelligence (AI) and finance industries are on the verge of collapse. "Within 5 years – maybe ...

Investing.com -- Wedbush Research added IBM (NYSE:IBM) to its Best Ideas List, highlighting the company's focus on balancing growth investments with improved operating efficiency. The firm expects ...

WASHINGTON, March 26, 2025 (GLOBE NEWSWIRE) -- Former CIA advisor and national economic strategist Jim Rickards is sounding the alarm on what he’s calling the “greatest cover-up in American ...

Andrew Harnik via Getty Images Long-time Tesla bull Dan Ives, an analyst at Wedbush Securities, says Elon Musk is the only one who can turn the EV maker's reputation around and the billionaire ...

BALTIMORE, March 18, 2025 (GLOBE NEWSWIRE) -- Jim Rickards, a former CIA advisor, is sounding the alarm on a looming energy crisis that could cripple U.S. infrastructure, disrupt financial markets, ...

Denise Richards claims Charlie Sheen was so jealous of her friendship with ex Patrick Muldoon that she cut him out of her life during their tumultuous marriage. “I did not speak to Pat when I ...

Wedbush analysts called Palantir one of their "top names" to own in 2025 despite recent losses. Shares of Palantir have lost one-third of their value in the wake of a report last month that the ...

And the process for doing so could be becoming less complicated. Wedbush Securities has been monitoring dozens of large firms, including Fortune 500 companies over the past few weeks, according to ...

Wedbush Securities is making a big statement on Tesla (NASDAQ:TSLA), naming it to its Best Ideas List even though the stock has had a rough start to the year. According to analyst Dan Ives, Tesla ...

IBM (NYSE:IBM) was in focus on Monday as Wedbush Securities added the IT giant to its Best Ideas List on the belief that software companies will benefit from the next round of artificial ...

Artiva Biotherapeutics (NASDAQ:ARTV – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities researchers at Wedbush in a note issued to investors on Tuesday ...